OBJECTIVES: Epidemiological data on musculoskeletal conditions such as degenerative joint diseases and bone fractures are lacking in low- and middle-income countries. This survey aimed to estimate the prevalence and causes of musculoskeletal impairment in Fundong Health District, North-West Cameroon. METHODS: Fifty-one clusters of 80 people (all ages) were selected using probability proportionate to size sampling. Households within clusters were selected by compact segment sampling. Six screening questions were asked to identify participants likely to have a musculoskeletal impairment (MSI). Participants screening positive to any screening question underwent a standardised examination by a physiotherapist to assess presence, cause, diagnosis and severity of impairment. RESULTS: In total, 3567 of 4080 individuals enumerated for the survey were screened (87%). The all-age prevalence of MSI was 11.6% (95% CI: 10.1-13.3). Prevalence increased with age, from 2.9% in children to 41.2% in adults 50 years and above. The majority of MSI cases (70.4%) were classified as mild, 27.2% as moderate and 2.4% as severe. Acquired non-trauma comprised 67% of the diagnoses. The remainder included trauma (14%), neurological (11%), infection (5%) and congenital (3%). The most common individual diagnosis was degenerative joint disease (43%). Over one-third (38%) of individuals with MSI had never received medical care or rehabilitation for their condition. CONCLUSIONS: This survey contributes to the epidemiological data on MSI in low- and middle-income countries. Nearly half of adults aged over 50 years had an MSI. There is a need to address the treatment and rehabilitative service gap for people with MSI in Cameroon.
OBJECTIVES: Epidemiological data on musculoskeletal conditions such as degenerative joint diseases and bone fractures are lacking in low- and middle-income countries. This survey aimed to estimate the prevalence and causes of musculoskeletal impairment in Fundong Health District, North-West Cameroon. METHODS: Fifty-one clusters of 80 people (all ages) were selected using probability proportionate to size sampling. Households within clusters were selected by compact segment sampling. Six screening questions were asked to identify participants likely to have a musculoskeletal impairment (MSI). Participants screening positive to any screening question underwent a standardised examination by a physiotherapist to assess presence, cause, diagnosis and severity of impairment. RESULTS: In total, 3567 of 4080 individuals enumerated for the survey were screened (87%). The all-age prevalence of MSI was 11.6% (95% CI: 10.1-13.3). Prevalence increased with age, from 2.9% in children to 41.2% in adults 50 years and above. The majority of MSI cases (70.4%) were classified as mild, 27.2% as moderate and 2.4% as severe. Acquired non-trauma comprised 67% of the diagnoses. The remainder included trauma (14%), neurological (11%), infection (5%) and congenital (3%). The most common individual diagnosis was degenerative joint disease (43%). Over one-third (38%) of individuals with MSI had never received medical care or rehabilitation for their condition. CONCLUSIONS: This survey contributes to the epidemiological data on MSI in low- and middle-income countries. Nearly half of adults aged over 50 years had an MSI. There is a need to address the treatment and rehabilitative service gap for people with MSI in Cameroon.
Authors: Ismail Yahaya; Tanya Wright; Opeyemi O Babatunde; Nadia Corp; Toby Helliwell; Lisa Dikomitis; Christian D Mallen Journal: Rheumatol Int Date: 2021-04-27 Impact factor: 2.631
Authors: Leonard Banza Ngoie; Eva Dybvik; Geir Hallan; Jan-Erik Gjertsen; Nyengo Mkandawire; Carlos Varela; Sven Young Journal: PLoS One Date: 2021-01-06 Impact factor: 3.240
Authors: Daniella M Cordero; Theodore A Miclau; Alexandra V Paul; Saam Morshed; Theodore Miclau; Claude Martin; David W Shearer Journal: OTA Int Date: 2020-04-23
Authors: Leonard Banza Ngoie; Eva Dybvik; Geir Hallan; Jan-Erik Gjertsen; Nyengo Mkandawire; Carlos Varela; Sven Young Journal: BMC Pediatr Date: 2022-01-28 Impact factor: 2.125
Authors: Dorothy Boggs; Hannah Kuper; Islay Mactaggart; Tess Bright; Gvs Murthy; Abba Hydara; Ian McCormick; Natalia Tamblay; Matias L Alvarez; Oluwarantimi Atijosan-Ayodele; Hisem Yonso; Allen Foster; Sarah Polack Journal: Int J Environ Res Public Health Date: 2022-04-03 Impact factor: 3.390
Authors: Islay Mactaggart; Nay Soe Maung; Cho Thet Khaing; Hannah Kuper; Karl Blanchet Journal: BMC Public Health Date: 2019-11-11 Impact factor: 3.295